SCEMBLIX 40 MG 60 F.C.TAB

ASCIMINIB IS A FIRST-IN-CLASS SPECIFIC ALLOSTERIC ORAL AND POTENT INHIBITOR OF ABL AND BCR::ABL1 TYROSINE KINASES. ASCIMINIB INHIBITS THE ABL1 KINASE ACTIVITY OF THE BCR::ABL1 FUSION PROTEIN BY SPECIFICALLY TARGETING THE ABL MYRISTOYL POCKET.^^INDICATIONS